Editas Medicine, Inc.
EDIT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001650664
In the last 90 days, Editas Medicine, Inc. insiders filed 0 open-market purchases and 5 sales; 215 institutions reported holding it in 13F filings for Q2 2026, worth $386.3M in total; no superinvestor holds it.
Q4 2023 vs. Q3 2023
How the institutions holding Editas Medicine, Inc. changed between Q3 2023 and Q4 2023.
All holders in Q4 2023All holders in Q3 2023
| Measure | Q3 2023 | Q4 2023 | Change |
|---|---|---|---|
| Holders | 222 | 226 | +4 |
| Shares | 61.0M | 58.8M | −2.22M (−3.6%) |
| Value | $481.0M | $595.7M | +$114.7M (+23.9%) |
New holders (38)
Institutions that held Editas Medicine, Inc. at the end of Q4 2023 but not at the end of Q3 2023.
Sold out (34)
Institutions that held Editas Medicine, Inc. at the end of Q3 2023 and filed for Q4 2023 without it.